Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Plasma Fractionation Market by Type of Company
... 9.2% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Company In-house Manufacturers Contract Service Providers Scale of Operation Preclinical Clinical Commercial Type ... Read More
-
Blood Disease Drugs Industry Forecasts - China Focus
... in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market ... Read More
-
Blood Disease Drugs Companies in China
... rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s ... Read More
-
Blood Disease Drugs Markets in China
... growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
... 11.04% during 2025-2033. The market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities ... Read More
-
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
... Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 PRODUCT OVERVIEW Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at ... Read More
-
Thalassemia Drugs Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Dual Chamber Prefilled Syringes Market, By Product Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), By Material Type (Glass and Plastic), By Indication (Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... One chamber contains the liquid drug component while the other holds the lyophilized or powder drug component. When the plunger is pressed, these two components are mixed homogeneously before injection. Its main advantage is the ... Read More
-
Thalassemia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031
... an estimated $12.9 billion by 2031 with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are the increased prevalence of thalassemia, the growing number of thalassemia medications under development, ... Read More
-
Global Rare Hematology Market - 2024 - 2031
... white blood cells, which makes it challenging to transfer oxygen and fight infections. A few conditions, such hemophagocytic lymphohistiocytosis, can be fatal. Cancerous and non-cancerous blood diseases both exist. The most prevalent non-cancerous blood condition ... Read More
-
Bone Marrow Transplant Market, By Type (Autologous Transplant, Allogenic Transplant, Others), By Treatment Type (Leukemia , Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle cell Anemia, Thalassemia, Others), By End User (Hospitals, Multi-specialty Clinics, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... lymphoma and other blood disorders. The stem cells can either be obtained from the patient (autologous transplant) or from a donor (allogeneic transplant). Allogeneic transplants have shown more success rates as compared to autologous as ... Read More
-
Hemophilia Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... therapies, extended half-life factor concentrates, and non-factor replacement therapies, are transforming patient care. Increasing awareness efforts from government and non-government organizations are further driving demand by improving diagnosis and treatment accessibility. Pharmaceutical companies and research ... Read More
-
Global Hemophilia Gene Therapy Industry Growth and Trends Forecast to 2031
... two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and ... Read More
-
China Genetic Testing Market Report by Test Type (Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing, Diagnostic Testing, and Others), Disease (Cancer, Down Syndrome, Thalassemia, and Others), Technology (Biochemical, Molecular, Cytogenetic), Service Provider (Hospital Based Laboratories, Independent Laboratories, Specialty Clinics), Testing Sample (Blood, Saliva, Hair, and Others) 2025-2033
... Genetic testing, also known as DNA testing, provides the determination of bloodlines and the genetic diagnosis of vulnerabilities to diseases that can be inherited. It determines changes in chromosomes, genes, or proteins. The results obtained ... Read More
-
Thalassemia Treatment
... CAGR of 6.5% over the analysis period 2024-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$560.0 Million by the end of the analysis ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution Form, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Iron Deficiency Anemia Therapy
... 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$11.1 Billion by ... Read More
-
Rare Hemophilia Factors
... at a CAGR of 5.6% over the analysis period 2024-2030. Fresh Frozen Plasma Treatment, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$246.9 Million by the ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Hemoglobinopathies
... 7.1% over the analysis period 2024-2030. Sickle Cell Disease Indication, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$795.0 Million by the end of the analysis ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
Research Assistance
